Analyzing Amneal Pharmaceuticals (NYSE:AMRX) and PLx Pharma (NASDAQ:PLXP)
Analyzing Amneal Pharmaceuticals (NYSE:AMRX) and PLx Pharma (NASDAQ:PLXP)
Amneal Pharmaceuticals (NYSE:AMRX – Get Rating) and PLx Pharma (NASDAQ:PLXP – Get Rating) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their risk, analyst recommendations, dividends, earnings, profitability, valuation and institutional ownership.
Amneal Pharmicals（紐約證券交易所代碼：AMRX — 獲取評級）和PLx Pharma（納斯達克股票代碼：PLXP — 獲取評級）都是小型醫療公司，但哪隻是優勢股？我們將根據兩家公司的風險強度、分析師建議、股息、收益、盈利能力、估值和機構所有權對比這兩家公司。
Risk & Volatility
風險與波動性
Amneal Pharmaceuticals has a beta of 1.32, suggesting that its share price is 32% more volatile than the S&P 500. Comparatively, PLx Pharma has a beta of 3.79, suggesting that its share price is 279% more volatile than the S&P 500.
Amneal Pharmicals的beta值爲1.32，這表明其股價的波動性比標準普爾500指數高32％。相比之下，Plx Pharma的beta值爲3.79，這表明其股價的波動性比標準普爾500指數高279％。
Analyst Recommendations
分析師建議
This is a breakdown of current recommendations and price targets for Amneal Pharmaceuticals and PLx Pharma, as provided by MarketBeat.
這是MarketBeat提供的Amneal Pharmicals和Plx Pharma的當前建議和目標價格的明細。
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Amneal Pharmaceuticals | 0 | 1 | 3 | 0 | 2.75 |
| PLx Pharma | 0 | 2 | 0 | 0 | 2.00 |
| 賣出評級 | 持有評級 | 買入評級 | 強勁的買入評級 | 評分分數 | |
| 健美製藥 | 0 | 1 | 3 | 0 | 2.75 |
| PLx Pharm | 0 | 2 | 0 | 0 | 2.00 |
Amneal Pharmaceuticals currently has a consensus price target of $3.75, suggesting a potential upside of 107.18%. Given Amneal Pharmaceuticals' stronger consensus rating and higher possible upside, research analysts clearly believe Amneal Pharmaceuticals is more favorable than PLx Pharma.
Amneal Pharmicals目前的共識目標股價爲3.75美元，表明潛在的上漲空間爲107.18％。鑑於Amneal Pharmaceals更強的共識評級和更高的可能上漲空間，研究分析師顯然認爲Amneal Pharmace比Plx Pharma更有利。
Profitability
盈利能力
This table compares Amneal Pharmaceuticals and PLx Pharma's net margins, return on equity and return on assets.
該表比較了Amneal Pharmicals和Plx Pharma的淨利潤率、股本回報率和資產回報率。
| Net Margins | Return on Equity | Return on Assets | |
| Amneal Pharmaceuticals | -5.88% | 76.11% | 4.68% |
| PLx Pharma | -606.91% | -291.11% | -119.43% |
| 淨利潤 | 股本回報率 | 資產回報率 | |
| 健美製藥 | -5.88% | 76.11% | 4.68% |
| PLx Pharm | -606.91% | -291.11% | -119.43% |
Institutional and Insider Ownership
機構所有權和內部所有權
32.8% of Amneal Pharmaceuticals shares are owned by institutional investors. Comparatively, 21.2% of PLx Pharma shares are owned by institutional investors. 26.8% of Amneal Pharmaceuticals shares are owned by insiders. Comparatively, 9.0% of PLx Pharma shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.
32.8％的Amneal Pharmicals股份由機構投資者持有。相比之下，Plx Pharma的股票中有21.2％由機構投資者持有。26.8％的Amneal Pharmicals股票由內部人士持有。相比之下，9.0％的Plx Pharma股票由內部人士持有。強大的機構所有權表明對沖基金、大型基金經理和捐贈機構認爲，從長遠來看，公司的表現將優於市場。
Valuation & Earnings
估值與收益
This table compares Amneal Pharmaceuticals and PLx Pharma's top-line revenue, earnings per share (EPS) and valuation.
該表比較了Amneal Pharmicals和Plx Pharma的收入、每股收益（EPS）和估值。
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Amneal Pharmaceuticals | $2.21 billion | 0.25 | -$129.99 million | ($0.86) | -2.10 |
| PLx Pharma | $4.54 million | 0.09 | -$46.13 million | ($1.85) | -0.01 |
| 總收入 | 價格/銷售比率 | 淨收入 | 每股收益 | 市盈率 | |
| 健美製藥 | 22.1 億美元 | 0.25 | -1.299 億美元 | (0.86 美元) | -2.10 |
| PLx Pharm | 454 萬美元 | 0.09 | -4613 萬美元 | (1.85 美元) | -0.01 |
PLx Pharma has lower revenue, but higher earnings than Amneal Pharmaceuticals. Amneal Pharmaceuticals is trading at a lower price-to-earnings ratio than PLx Pharma, indicating that it is currently the more affordable of the two stocks.
Plx Pharma的收入較低，但收益高於Amneal Pharmicals。Amneal Pharmicals的交易市盈率低於PLx Pharma，這表明它目前是這兩隻股票中更實惠的一隻。
Summary
摘要
Amneal Pharmaceuticals beats PLx Pharma on 11 of the 14 factors compared between the two stocks.
與兩隻股票相比，Amneal Pharmicals在14個因素中有11個擊敗了PLx Pharma。
About Amneal Pharmaceuticals
關於 Amneal Ph
(Get Rating)
（獲取評級）
Amneal Pharmaceuticals, Inc. is a pharmaceutical company, which engages in the development, manufacture, market and distribution of generic pharmaceutical products. It operates through the Generic, Specialty and AvKARE Segments. The Generics segment develops, manufactures and commercializes complex oral solids, injectables, ophthalmics, liquids, topicals, softgels, inhalation products and transdermals. The Specialty segment provides proprietary medicines to the U.S. market. The AvKARE segment focuses on pharmaceuticals, medical and surgical products, and services primarily to governmental agencies. The company was founded by Chintu Patel and Chirag Patel in 2002 and is headquartered in Bridgewater, NJ.
Amneal Pharmicals, Inc. 是一家制藥公司，從事仿製藥產品的開發、製造、營銷和分銷。它通過通用、專業和AVkare細分市場運營。Generics部門開發、製造和商業化複雜的口服固體、注射劑、眼科藥物、液體、外用藥物、軟膠囊、吸入產品和透皮藥物。專業領域向美國市場提供專有藥物。AvKare部門專注於藥品、醫療和外科產品，以及主要爲政府機構提供的服務。該公司由欽圖·帕特爾和奇拉格·帕特爾於2002年創立，總部位於新澤西州布里奇沃特。
About PLx Pharma
關於 PLx Pharma
(Get Rating)
（獲取評級）
PLx Pharma, Inc. is a late-stage specialty pharmaceutical company, which engages in the development and commercialization of technology platform for approved drugs. It offers PLxGuard delivery system, which uses surface acting lipids, such as phospholipids and free fatty acids, to modify the physiochemical properties of various drugs with a targeted release to select portions of the gastrointestinal (GI) tract. The company was founded by Ronald R. Zimmerman on November 12, 2002 and is headquartered in Sparta, NJ.
Plx Pharma, Inc. 是一家處於後期階段的專業製藥公司，從事已批准藥物的技術平臺的開發和商業化。它提供PLXGuard輸送系統，該系統使用表面作用的脂質，例如磷脂和遊離脂肪酸，通過靶向釋放到胃腸道（GI）的部分來改變各種藥物的物理化學特性。該公司由羅納德·齊默爾曼於 2002 年 11 月 12 日創立，總部位於新澤西州斯巴達。
Receive News & Ratings for Amneal Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amneal Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
接收 Amneal Pharmicals Daily -在下面輸入您的電子郵件地址，通過Marketbeat.com的免費每日電子郵件時事通訊接收Amneal Pharmicals及相關公司的最新新聞和分析師評級的簡明每日摘要。
譯文內容由第三人軟體翻譯。